FT Vest U.S. Equity Deep Buffer ETF - October (DOCT)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) with AI Score 47/100 (Weak). FT Vest U. S. Equity Deep Buffer ETF - October seeks to match the price return of the SPDR S&P 500 ETF Trust, with a capped upside and a buffer against losses. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 17, 2026FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) Financial Services Profile
FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) offers a buffered exposure to the SPDR S&P 500 ETF Trust, targeting a capped upside of 11.73% and buffering against losses between -5% and -30% from October 2025 to October 2026. This fund caters to investors seeking defined risk management within the asset management sector.
Investment Thesis
DOCT presents a targeted investment strategy for investors seeking defined risk parameters. The fund's capped upside of 11.73% and buffered downside between -5% and -30% offer a specific risk-return profile relative to the SPDR S&P 500 ETF Trust from October 2025 to October 2026. A key value driver is the fund's ability to attract investors who prioritize downside protection and are willing to forgo some potential upside. Growth catalysts include increased investor awareness of defined outcome ETFs and a growing demand for risk management tools. The fund's success depends on its ability to accurately track the SPDR S&P 500 ETF Trust and maintain its defined buffer and cap levels. Potential risks include tracking error, changes in market volatility, and competition from similar products.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.31B indicates moderate investor interest and fund size.
- Beta of 0.49 suggests lower volatility compared to the broader market, aligning with the fund's buffered strategy.
- The fund's defined outcome period from October 20, 2025, to October 16, 2026, provides a clear timeframe for its investment strategy.
- The upside cap of 11.73% limits potential gains but offers a defined return target.
- The buffer against losses between -5% and -30% provides downside protection during the specified period.
Competitors & Peers
Strengths
- Defined risk-return profile.
- Buffered downside protection.
- Capped upside potential.
- Specific time horizon.
Weaknesses
- Limited upside potential.
- Tracking error risk.
- Reliance on the performance of the SPDR S&P 500 ETF Trust.
- Complexity of the investment strategy.
Catalysts
- Upcoming: Increased investor awareness of defined outcome ETFs.
- Ongoing: Growing demand for risk management tools.
- Ongoing: Expansion of the defined outcome ETF market.
Risks
- Potential: Tracking error between the fund's performance and the SPDR S&P 500 ETF Trust.
- Potential: Changes in market volatility affecting the fund's performance.
- Potential: Competition from other defined outcome ETFs.
- Ongoing: Regulatory changes impacting the ETF industry.
Growth Opportunities
- Increased Adoption of Defined Outcome ETFs: The growing awareness and acceptance of defined outcome ETFs present a significant growth opportunity for DOCT. As investors seek strategies to navigate market volatility and manage risk, defined outcome ETFs are becoming increasingly attractive. The market for these products is expanding, driven by demand from both retail and institutional investors. DOCT can capitalize on this trend by educating investors about its specific risk-return profile and highlighting its benefits in a volatile market environment.
- Expansion of Product Line: FT Vest could expand its suite of defined outcome ETFs to offer different cap levels, buffer ranges, and underlying indexes. This would allow the company to cater to a wider range of investor preferences and risk tolerances. For example, the company could launch ETFs that track different market segments or offer different levels of downside protection. This diversification of product offerings would enhance the company's competitive position and attract new investors.
- Partnerships with Financial Advisors: Collaborating with financial advisors can significantly expand DOCT's reach and distribution. Financial advisors play a crucial role in educating clients about investment products and recommending suitable strategies. By partnering with financial advisory firms, DOCT can gain access to a broader investor base and increase its assets under management. These partnerships can involve training programs, marketing materials, and other initiatives to promote the benefits of DOCT to financial advisors and their clients.
- Enhanced Marketing and Education: Investing in marketing and educational initiatives can help DOCT raise awareness and attract new investors. This can include online advertising, social media campaigns, webinars, and educational content that explains the fund's strategy and benefits. By effectively communicating its value proposition, DOCT can differentiate itself from competitors and attract investors who are seeking defined outcome solutions. A strong marketing and education strategy is essential for driving growth and increasing market share.
- Institutional Adoption: While defined outcome ETFs have primarily been adopted by retail investors, there is a growing opportunity to attract institutional investors. These investors, such as pension funds and endowments, are increasingly seeking strategies to manage risk and generate consistent returns. DOCT can target institutional investors by highlighting its defined risk-return profile and its potential to enhance portfolio diversification. Successfully attracting institutional investors would significantly increase DOCT's assets under management and drive long-term growth.
Opportunities
- Growing demand for defined outcome ETFs.
- Expansion of product line with different cap levels and buffer ranges.
- Partnerships with financial advisors.
- Increased institutional adoption.
Threats
- Competition from other defined outcome ETFs.
- Changes in market volatility.
- Regulatory changes.
- Economic downturn.
Competitive Advantages
- Defined Outcome Strategy: Offers a unique investment approach with a capped upside and buffered downside.
- Specific Time Horizon: Provides a defined investment period, catering to investors with specific goals.
- Brand Recognition: FT Vest is a recognized provider of defined outcome ETFs.
About DOCT
The FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) is designed to provide investors with a unique investment strategy focused on defined outcome investing. The fund seeks to replicate the price return of the SPDR S&P 500 ETF Trust (SPY) up to a predetermined upside cap, while also providing a buffer against a specific range of losses. This strategy is implemented over a defined period, from October 20, 2025, to October 16, 2026. The fund's objective is to offer investors a balance between potential gains and downside protection. DOCT does not have a traditional founding story like operating companies. It was created as part of a suite of defined outcome ETFs. The ETF's evolution is tied to the growing demand for investment products that offer more predictable risk-return profiles. The fund operates within the asset management industry, providing a specific type of investment vehicle. The fund's geographic reach is primarily the U.S. market, as it tracks the SPDR S&P 500 ETF Trust. DOCT competes with other ETFs and investment products that offer similar defined outcome strategies or buffered exposure to the S&P 500. Its competitive positioning relies on the specific cap and buffer levels it offers, as well as its expense ratio and trading liquidity.
What They Do
- Provides investors with exposure to the SPDR S&P 500 ETF Trust (SPY).
- Offers a capped upside return, limiting potential gains to a predetermined level.
- Provides a buffer against a specific range of losses in the SPY.
- Operates over a defined period, from October 20, 2025, to October 16, 2026.
- Seeks to match the price return of the SPDR S&P 500 ETF Trust up to 11.73%.
- Buffers against Underlying ETF losses between -5% and -30%.
Business Model
- The fund generates revenue through management fees charged to investors.
- The management fee is a percentage of the fund's assets under management (AUM).
- The fund's profitability depends on its ability to attract and retain investors, as well as its expense management.
Industry Context
DOCT operates within the asset management industry, specifically in the growing segment of defined outcome ETFs. These ETFs aim to provide investors with a more predictable risk-return profile compared to traditional index funds. The market for defined outcome ETFs has been expanding as investors seek tools to manage volatility and achieve specific financial goals. The competitive landscape includes other ETF providers offering similar buffered or capped strategies, such as BJAN, BJUL, DECW, DJUN, and GAUG. The growth of this segment is driven by factors such as increased market volatility and a greater focus on risk management.
Key Customers
- Retail investors seeking defined risk-return profiles.
- Financial advisors looking for tools to manage client portfolios.
- Institutional investors seeking downside protection strategies.
Financials
Chart & Info
FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) stock price: Price data unavailable
Latest News
No recent news available for DOCT.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DOCT.
Price Targets
Wall Street price target analysis for DOCT.
MoonshotScore
What does this score mean?
The MoonshotScore rates DOCT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
DOCT Financial Services Stock FAQ
What does FT Vest U.S. Equity Deep Buffer ETF - October do?
FT Vest U.S. Equity Deep Buffer ETF - October seeks to provide investors with a return profile that matches the price return of the SPDR S&P 500 ETF Trust, up to a predetermined upside cap of 11.73%, while buffering against losses between -5% and -30% over the period from October 20, 2025 to October 16, 2026. This defined outcome strategy aims to offer a balance between potential gains and downside protection, targeting investors with specific risk management needs.
What do analysts say about DOCT stock?
AI analysis is pending for DOCT. Generally, analysts covering ETFs in the asset management sector focus on factors such as expense ratios, tracking error, liquidity, and the effectiveness of the fund's stated strategy. For defined outcome ETFs like DOCT, key considerations include the accuracy of the buffer and cap levels, as well as the fund's ability to deliver its intended risk-return profile. Investors should consult independent financial advice before making any investment decisions.
What are the main risks for DOCT?
The main risks for DOCT include tracking error, which could cause the fund's performance to deviate from the SPDR S&P 500 ETF Trust. Changes in market volatility can also impact the fund's performance and the effectiveness of its buffer and cap levels. Competition from other defined outcome ETFs is another risk, as investors may choose alternative products with different risk-return profiles. Regulatory changes in the ETF industry could also affect the fund's operations and profitability. Investors should carefully consider these risks before investing in DOCT.
What are the key factors to evaluate for DOCT?
FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) currently holds an AI score of 47/100, indicating low score. Key strength: Defined risk-return profile.. Primary risk to monitor: Potential: Tracking error between the fund's performance and the SPDR S&P 500 ETF Trust.. This is not financial advice.
How frequently does DOCT data refresh on this page?
DOCT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DOCT's recent stock price performance?
Recent price movement in FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Defined risk-return profile.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DOCT overvalued or undervalued right now?
Determining whether FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DOCT?
Before investing in FT Vest U.S. Equity Deep Buffer ETF - October (DOCT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and is subject to change.
- AI analysis is pending for DOCT.